Extrait

The purpose of this study is to evaluate the effectiveness (improvement of signs and symptoms) and safety of ustekinumab in participants with active psoriatic arthritis.

Critère d'inclusion

• Arthritis, Psoriatic

Pays

• Australia
• Austria
• Canada
• Finland
• Germany
• Hungary
• Latvia
• Lithuania
• New Zealand
• Poland
• Russian Federation
• Spain
• United Kingdom
• United States

Liens

• ictrp
• nct